[1]杨丽艳,赵宝宁,杨贺庆,等.半夏泻心汤联合美沙拉嗪治疗轻度活动期克罗恩病疗效研究[J].陕西中医,2021,(9):1240-1242.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.023]
 YANG Liyan,ZHAO Baoning,YANG Heqing,et al.Efficacy study on Banxia Xiexin decoction combined with mesalazine in treatment of mild active Crohn's disease[J].,2021,(9):1240-1242.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.023]
点击复制

半夏泻心汤联合美沙拉嗪治疗轻度活动期克罗恩病疗效研究
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1240-1242
栏目:
临床研究
出版日期:
2021-09-05

文章信息/Info

Title:
Efficacy study on Banxia Xiexin decoction combined with mesalazine in treatment of mild active Crohn's disease
作者:
杨丽艳赵宝宁杨贺庆尹学永齐建丽马月娜王茜姊
(秦皇岛市第二医院,河北 秦皇岛 066600)
Author(s):
YANG LiyanZHAO BaoningYANG HeqingYIN XueyongQI JianliMA YuenaWANG Qianzi
(Qinhuangdao Second Hospital,Qinhuangdao 066600,China)
关键词:
克罗恩病 半夏泻心汤 美沙拉嗪 中医症候 炎症因子 生活质量
Keywords:
Crohn's disease Banxia Xiexin decoction Mesalazine TCM Syndrome Inflammatory factors Quality of life
分类号:
R 516.1
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.023
文献标志码:
A
摘要:
目的:探讨半夏泻心汤联合美沙拉嗪治疗轻度活动期克罗恩病的临床疗效。方法:选择82例克罗恩病患者,随机分为两组,各41例。对照组接受美沙拉嗪治疗,观察组联合应用半夏泻心汤治疗,疗程均为8周。结果:治疗后,观察组中医证候临床缓解率、总有效率高于对照组,差异有统计学意义(均P<0.05)。治疗后,两组克罗恩疾病活动指数(CDAI)评分均降低,炎症性肠病生活质量问卷(IBDQ)评分均升高,且观察组优于对照组,差异有统计学意义(均P<0.05)。治疗后两组ESR、血清TNF-α、IL-6水平均降低,且观察组水平均低于对照组,差异有统计学意义(均P<0.05)。结论:半夏泻心汤联合美沙拉嗪治疗轻度活动期克罗恩病患者可以有效缓解临床症状,抑制炎症反应,提高临床疗效,改善患者生活质量。
Abstract:
Objective:To explore clinical effect of Banxia Xiexin decoction combined with mesalazine in treatment of mild active Crohn's disease.Methods:82 patients with Crohn's disease were randomly divided into two groups,41 cases in each group.The control group was treated with mesalazine.The observation group was treated combined with Banxia Xiexin decoction.The course of treatment was 8 weeks.Results:Compared with the control group,the clinical remission rate and total effective rate in the observation group were higher,difference statisticsally significant(all P<0.05).After treatment,the CDAI scores of both groups were decreased,and the IBDQ score increased,and the observation group were better than the control group,differences statisticsally significant(all P<0.05).After treatment,ESR and serum TNF-α,IL-6 levels in both groups were significantly lower,and above indicators observation group lower than those in the control group,difference statisticsally significant(all P<0.05).Conclusion:Banxia Xiexin decoction combined with mesalazine can effectively relieve clinical symptoms of patients with mild active Crohn's disease,inhibit inflammatory reaction and improve clinical efficacy and quality of life.

参考文献/References:

[1] 李 毅,曹 磊,郭 振,等.单中心1048例克罗恩病手术患者临床特点及预后分析[J].中华外科杂志,2021,59(1):40-45.
[2] 黎 苗,高 翔,赵俊章,等.克罗恩病上消化道病变的临床、内镜及病理特征分析[J].中华炎性肠病杂志:中英文,2018,2(4):279-283.
[3] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见[J].中华消化杂志,2018,38(5):292-311.
[4] 张海洋,宋 展,钱国武,等.四君子汤加味治疗克罗恩病的临床疗效和对炎症因子的调节作用[J].中国实验方剂学杂志,2018,24(17):172-176.
[5] Ren WH,Lai M,Chen Y,et al.Validation of the main land Chinese version of the inflammatory bowel disease questionnaire for ulcerative colitis and Crohn's disease[J].Inflamm Bowel Dis,2007,13(7):903-910.
[6] 崔德军,杨柳婵,杨小兰,等.贵州地区克罗恩病发病的危险因素[J].临床与病理杂志,2018,38(9):1913-1916.
[7] Khanna S,Raffals LE.The microbiome in Crohn's disease:Role in pathogenesis and role of microbiome replacement therapies[J].Gastroenterol Clin North Am,2017,46(3):481-492.
[8] 王 玥,姜相君.克罗恩病的药物治疗进展[J].中国医刊,2017,52(1):26-30.
[9] 郭佳佳.美沙拉嗪联合薁磺酸钠治疗溃疡性直肠炎疗效及对患者血清炎性因子水平影响研究[J].陕西医学杂志,2018,47(3):386-388.
[10] 孙 柱.四君子汤联合美沙拉嗪治疗克罗恩病临床观察[J].实用中医药杂志,2018,34(10):1186-1187.
[11] Chen YC,Chen FP,Chen TJ,et al.Patterns of traditional Chinese medicine use in patients with inflammatory bowel disease:Apopulation study in Taiwan[J].Hepato- gastroenterology,2008,55(82):467-470.
[12] 栗梦晓,赵文霞.克罗恩病病因病机探析[J].山东中医药大学学报,2020,44(4):396-399.
[13] 李义超,陈招润,骆超宇.半夏泻心汤治疗脾胃疾病的临床经验[J].四川中医,2019,37(7):28-30.
[14] 王艳威,季 杰,巩子汉,等.半夏泻心汤加减治疗慢性萎缩性胃炎脾胃湿热证临床研究[J].陕西中医,2020,41(4):499-501,537.
[15] 史圣华,莫日根,王生义,等.半夏泻心汤对老年HP阳性慢性胃炎患者胃动力及胃肠激素的影响[J].中国老年学杂志,2020,40(20):4324-4327.
[16] 梁雪冰,孙 俊,赵国平.半夏泻心汤活性成分最佳组合筛选及其对胃溃疡大鼠Leptin、ET-1的影响[J].中药材,2012,35(10):1637-1640.
[17] 彭陈文,刘凤斌,王 森,等.半夏泻心汤抗消化性溃疡作用机制的网络药理学研究[J].中药新药与临床药理,2019,30(12):1479-1484.
[18] 吴万桂,杨 剑,张 杰.克罗恩病患者外周血Th17、Treg比例变化及其临床意义[J].山东医药,2018,58(24):64-66.
[19] 陈 丹,陈 洋,李 骥,等.血清IL-6与TNF-α在克罗恩病疾病评估中的应用[J].胃肠病学和肝病学杂志,2020,29(3):279-284.
[20] 王云滨,陈 霞.益生菌联合美沙拉嗪对溃疡性结肠炎患者血清炎症因子及免疫功能的影响[J].中国现代医生,2020,58(9):40-43.

相似文献/References:

[1]冯 璇,寇 玉,薛 峰,等.半夏泻心汤治疗胃黏膜异型增生疗效及对患者胃癌相关基因甲基化的影响[J].陕西中医,2021,(8):1020.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.008]
 FENG Xuan,KOU Yu,XUE Feng,et al.Therapeutic efficacy of Banxia Xiexin decoction on gastric epithelial dysplasia and its effects on relative genes of gastric cancer[J].,2021,(9):1020.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.008]
[2]陶 冉,黄晓琳,龚恬韵,等.克罗恩病肛瘘中医药治疗研究进展[J].陕西中医,2022,(5):666.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.029]
 TAO Ran,HUANG Xiaolin,GONG Tianyun,et al.Research progress of traditional Chinese medicine in the treatment of anal fistula in Crohn's disease[J].,2022,(9):666.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.029]
[3]薛雁文,尹晓慧,杨 萍,等.针刺调控内质网应激治疗炎症性肠病研究进展[J].陕西中医,2023,(8):1157.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.038]
 XUE Yanwen,YIN Xiaohui,YANG Ping,et al.Research progress of acupuncture regulating endoplasmic reticulum stress in the treatment of inflammatory bowel disease[J].,2023,(9):1157.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.038]
[4]贡钰霞,王 浩.名中医谷云飞内外治结合治疗克罗恩病肛瘘经验[J].陕西中医,2023,(9):1277.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.028]
 GONG Yuxia,WANG Hao.The experience of Gu Yunfei in treating anal fistula of Crohn's disease with internal and external treatment[J].,2023,(9):1277.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.028]
[5]耿 琦,李敬伟,凌江红,等.半夏泻心汤对功能性消化不良大鼠抑郁状态及促肾上腺皮质激素释放因子相关通路的影响[J].陕西中医,2024,(2):147.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.001]
 GENG Qi,LI Jingwei,LING Jianghong,et al.Effects of Banxia Xiexin decoction on depressive state and CRF-related pathways in rats with functional dyspepsia[J].,2024,(9):147.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.001]
[6]王素盈,马佳乐,索卓群,等.名中医李慧臻内外并治分期辨治慢性萎缩性胃炎经验[J].陕西中医,2025,46(2):245.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.021]
 WANG Suying,MA Jiale,SUO Zhuoqun,et al.Professor LI Huizhen's experience in treating chronic atrophic gastritis by internal and external stages[J].,2025,46(9):245.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.021]

备注/Memo

备注/Memo:
基金项目:河北省卫生健康委员会课题(20191369)
更新日期/Last Update: 2021-09-10